The Latest Cardiac and Vascular News
– CGuard™ Carotid Stent will now be a treatment option in the stenting plus medical therapy arm of the trial for patients – – CREST-2 Trial is sponsored by the National Institute of Neurological Disorders and Stroke (NINDS) and actively engaged at more than 140 study locations – TEL AVIV, Israel, Feb. […]
Data Presented at Cardiovascular Research Technologies (CRT) Annual Conference SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced the presentation of results from the first animal study of its transcatheter valve from the TRIA™ biopolymer heart valve portfolio this past weekend at the Cardiovascular Research Technologies (CRT) annual conference. The transcatheter TRIA […]
SUNNYVALE, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2021. “Our team and physicians had a tremendous impact […]
BURLINGTON, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) — LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2021 results, announced a $0.125/share quarterly dividend (+14%) and provided guidance. Q4 2021 Financial Results Sales of $39.5mm, +5% (+6% organic) vs. Q4 2020 Op. income of $8.3mm, -13% Op. margin […]
– Alignment signals recognition of Terumo Health Outcomes’ proprietary ePRISM® technology using precision medicine to improve outcomes for cardiac patients and Corazon accreditation as a means to monitor and recognize such improvements – SOMERSET, N.J., Feb. 25, 2022 /PRNewswire/ — Terumo Health Outcomes, a division of Terumo Medical Corporation, a leading global […]
– Jardiance is the first and only heart failure therapy to demonstrate a statistically significant risk reduction in cardiovascular death and hospitalization for heart failure, regardless of ejection fraction – FDA approval marks a significant breakthrough for the approximately 3 million adults in the U.S. with heart failure with preserved ejection fraction, […]
Commercial Launch Readiness Activities Underway for Omecamtiv Mecarbil in Advance of PDUFA Date of November 30, 2022 SEQUOIA-HCM Open to Enrollment; Development Program for Aficamten Expanding in 2022 Company Provides 2022 Financial Guidance; More Than 2 Years of Cash Runway SOUTH SAN FRANCISCO, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Cytokinetics, […]
MEMPHIS, Tenn., Feb. 25, 2022 (GLOBE NEWSWIRE) — Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease (PAD), expands its footprint with its newest clinic at 5645 Murray Ave., in Memphis. Board-Certified Vascular and interventional Radiologist, Samuel G. Putnam III, MD, FSIR, will manage the new clinic. […]
Q4 2021 reported revenue of $278.5 million, up 7.9% on a reported basis and up 8.4% on a constant currency revenue, organic* basis, compared to Q4 2020 Q4 2021 GAAP EPS increased 32% year-over-year to $0.36, compared to $0.27 in Q4 2020 Q4 2021 non-GAAP EPS* increased 31% year-over-year to […]
PRAIRIE VILLAGE, Kan., Feb. 24, 2022 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced the hiring of Dan Tamez as Senior Director of Nonclinical and Clinical Research and the engagement of Geoff Tansley, PhD as Senior R&D Consultant. Tamez will lead nonclinical […]
